Cerus (CERS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

CERS Stock Forecast


Cerus stock forecast is as follows: an average price target of $3.00 (represents a 87.50% upside from CERS’s last price of $1.60) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

CERS Price Target


The average price target for Cerus (CERS) is $3.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential 87.50% upside from CERS's last price of $1.60.

CERS Analyst Ratings


Buy

According to 4 Wall Street analysts, Cerus's rating consensus is 'Buy'. The analyst rating breakdown for CERS stock is 0 'Strong Buy' (0.00%), 3 'Buy' (75.00%), 1 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Cerus Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 17, 2024Mathew BlackmanStifel Nicolaus$3.00$1.8066.67%87.50%
May 03, 2024Brandon FolkesCantor Fitzgerald$4.00$1.76127.27%150.00%
Apr 12, 2024Bill BonelloCraig-Hallum$5.00$1.79179.33%212.50%

The latest Cerus stock forecast, released on Oct 17, 2024 by Mathew Blackman from Stifel Nicolaus, set a price target of $3.00, which represents a 66.67% increase from the stock price at the time of the forecast ($1.80), and a 87.50% increase from CERS last price ($1.60).

Cerus Price Target by Period


1M3M12M
# Anlaysts-13
Avg Price Target-$3.00$4.00
Last Closing Price$1.60$1.60$1.60
Upside/Downside-100.00%87.50%150.00%

In the current month, the average price target of Cerus stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cerus's last price of $1.60. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 17, 2024Cowen & Co.BuyBuyHold
Aug 05, 2024BTIGNeutralNeutralHold
May 03, 2024Cantor FitzgeraldOverweightOverweightHold
Apr 12, 2024Craig-HallumBuyInitialise

Cerus's last stock rating was published by Cowen & Co. on Oct 17, 2024. The company gave CERS a "Buy" rating, the same as its previous rate.

Cerus Financial Forecast


Cerus Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$46.77M$39.77M$38.85M$30.97M$44.03M$39.57M$41.00M$37.44M$50.09M$42.10M$37.76M$29.57M$33.59M$29.19M$26.83M$24.64M$26.49M$22.85M
Avg Forecast$62.44M$59.70M$58.38M$51.80M$59.32M$56.72M$55.36M$49.84M$53.76M$50.82M$47.63M$43.23M$53.57M$48.73M$47.65M$38.40M$49.16M$46.83M$46.01M$41.67M$43.90M$37.26M$31.40M$27.54M$28.20M$28.60M$25.89M$22.80M$25.30M$22.60M
High Forecast$65.69M$62.81M$61.43M$54.50M$62.41M$59.68M$58.24M$52.35M$56.56M$51.28M$47.63M$43.23M$56.36M$51.27M$50.14M$40.40M$51.73M$46.83M$46.01M$41.67M$43.90M$37.26M$31.40M$27.54M$28.20M$28.60M$25.89M$22.80M$25.30M$22.60M
Low Forecast$59.21M$56.61M$55.36M$49.12M$56.25M$53.79M$52.49M$46.68M$50.97M$50.36M$47.63M$43.23M$50.79M$46.21M$45.19M$36.41M$46.62M$46.83M$46.01M$41.67M$43.90M$37.26M$31.40M$27.54M$28.20M$28.60M$25.89M$22.80M$25.30M$22.60M
# Analysts1111111331113111111111111010101099
Surprise %------------0.87%0.82%0.82%0.81%0.90%0.84%0.89%0.90%1.14%1.13%1.20%1.07%1.19%1.02%1.04%1.08%1.05%1.01%

Cerus's average Quarter revenue forecast for Mar 24 based on 1 analysts is $43.23M, with a low forecast of $43.23M, and a high forecast of $43.23M. CERS's average Quarter revenue forecast represents a -7.57% decrease compared to the company's last Quarter revenue of $46.77M (Dec 23).

Cerus EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111331113111111111111010101099
EBITDA------------$976.00K$-5.24M$-11.64M$-14.15M$-9.95M$-6.57M$-6.10M$-9.77M$-6.90M$-10.32M$-13.17M$-15.59M$-12.53M$-12.33M$-13.09M$-14.77M$-15.26M$-17.00M
Avg Forecast$-26.92M$-25.74M$-25.17M$-22.33M$-25.58M$-24.46M$-23.87M$-21.49M$-23.18M$-21.91M$-20.54M$-14.73M$-23.10M$-21.01M$-20.55M$-13.39M$-10.44M$-22.98M$-22.58M$-12.18M$-21.54M$-18.28M$-15.41M$-13.86M$-13.84M$-14.04M$-12.70M$-14.77M$-12.41M$-11.09M
High Forecast$-25.53M$-24.41M$-23.87M$-21.18M$-24.25M$-23.19M$-22.63M$-20.13M$-21.98M$-21.71M$-20.54M$-11.79M$-21.90M$-19.93M$-19.48M$-10.72M$-8.35M$-22.98M$-22.58M$-9.74M$-21.54M$-18.28M$-15.41M$-11.09M$-13.84M$-14.04M$-12.70M$-11.81M$-12.41M$-11.09M
Low Forecast$-28.32M$-27.08M$-26.48M$-23.50M$-26.91M$-25.73M$-25.11M$-22.57M$-24.39M$-22.11M$-20.54M$-17.68M$-24.30M$-22.11M$-21.62M$-16.07M$-12.53M$-22.98M$-22.58M$-14.61M$-21.54M$-18.28M$-15.41M$-16.63M$-13.84M$-14.04M$-12.70M$-17.72M$-12.41M$-11.09M
Surprise %-------------0.04%0.25%0.57%1.06%0.95%0.29%0.27%0.80%0.32%0.56%0.85%1.13%0.91%0.88%1.03%1.00%1.23%1.53%

1 analysts predict CERS's average Quarter EBITDA for Mar 24 to be $-14.73M, with a high of $-11.79M and a low of $-17.68M. This is -1609.65% lower than Cerus's previous annual EBITDA (Dec 23) of $976.00K.

Cerus Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111331113111111111111010101099
Net Income------------$-1.33M$-7.27M$-13.28M$-15.64M$-13.63M$-8.52M$-8.39M$-12.28M$-9.12M$-12.44M$-15.36M$-17.46M$-14.38M$-14.14M$-14.87M$-16.47M$-16.92M$-17.97M
Avg Forecast$-1.85M$-2.78M$-2.78M$-8.34M$-1.85M$-2.78M$-3.24M$-6.03M$-2.60M$-5.93M$-7.79M$-18.17M$-5.10M$-9.89M$-10.66M$-16.52M$-13.79M$-10.64M$-12.95M$-15.01M$-14.34M$-17.57M$-18.04M$-15.52M$-16.11M$-18.50M$-20.35M$-16.47M$-21.58M$-22.20M
High Forecast$-1.73M$-2.59M$-2.59M$-7.78M$-1.73M$-2.59M$-3.03M$-5.17M$-2.42M$-5.53M$-7.26M$-14.53M$-4.76M$-9.22M$-9.94M$-13.21M$-11.03M$-10.64M$-12.95M$-12.01M$-14.34M$-17.57M$-18.04M$-12.41M$-16.11M$-18.50M$-20.35M$-13.17M$-21.58M$-22.20M
Low Forecast$-1.98M$-2.97M$-2.97M$-8.91M$-1.98M$-2.97M$-3.46M$-6.89M$-2.77M$-6.34M$-8.32M$-21.80M$-5.44M$-10.56M$-11.38M$-19.82M$-16.55M$-10.64M$-12.95M$-18.02M$-14.34M$-17.57M$-18.04M$-18.62M$-16.11M$-18.50M$-20.35M$-19.76M$-21.58M$-22.20M
Surprise %------------0.26%0.73%1.25%0.95%0.99%0.80%0.65%0.82%0.64%0.71%0.85%1.13%0.89%0.76%0.73%1.00%0.78%0.81%

Cerus's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CERS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Cerus SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111331113111111111111010101099
SG&A------------$17.27M$16.16M$20.54M$21.55M$23.16M$19.91M$19.53M$20.73M$22.00M$20.36M$19.76M$19.17M$18.69M$16.30M$16.11M$15.91M$17.16M$16.14M
Avg Forecast$40.39M$38.62M$37.77M$33.51M$38.37M$36.69M$35.81M$32.24M$34.77M$32.87M$30.81M$30.66M$34.65M$31.53M$30.83M$27.88M$33.28M$30.29M$29.76M$25.34M$28.39M$24.10M$20.31M$17.04M$18.24M$18.50M$16.75M$15.91M$16.36M$14.62M
High Forecast$42.49M$40.63M$39.73M$35.25M$40.37M$38.60M$37.67M$33.86M$36.58M$33.17M$30.81M$36.80M$36.46M$33.17M$32.43M$33.45M$39.94M$30.29M$29.76M$30.41M$28.39M$24.10M$20.31M$20.45M$18.24M$18.50M$16.75M$19.10M$16.36M$14.62M
Low Forecast$38.30M$36.62M$35.81M$31.77M$36.39M$34.79M$33.95M$30.20M$32.97M$32.57M$30.81M$24.53M$32.86M$29.89M$29.23M$22.30M$26.62M$30.29M$29.76M$20.27M$28.39M$24.10M$20.31M$13.63M$18.24M$18.50M$16.75M$12.73M$16.36M$14.62M
Surprise %------------0.50%0.51%0.67%0.77%0.70%0.66%0.66%0.82%0.77%0.84%0.97%1.13%1.02%0.88%0.96%1.00%1.05%1.10%

Cerus's average Quarter SG&A projection for Mar 24 is $30.66M, based on 1 Wall Street analysts, with a range of $24.53M to $36.80M. The forecast indicates a 77.57% rise compared to CERS last annual SG&A of $17.27M (Dec 23).

Cerus EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111331113111111111111010101099
EPS------------$-0.01$-0.04$-0.07$-0.09$-0.08$-0.05$-0.05$-0.07$-0.05$-0.07$-0.09$-0.10$-0.09$-0.08$-0.09$-0.10$-0.12$-0.13
Avg Forecast$-0.01$-0.01$-0.01$-0.04$-0.01$-0.01$-0.02$-0.03$-0.01$-0.03$-0.04$-0.05$-0.03$-0.05$-0.06$-0.08$-0.06$-0.06$-0.07$-0.08$-0.08$-0.10$-0.10$-0.10$-0.09$-0.10$-0.11$-0.11$-0.12$-0.12
High Forecast$-0.01$-0.01$-0.01$-0.04$-0.01$-0.01$-0.02$-0.03$-0.01$-0.03$-0.04$-0.04$-0.03$-0.05$-0.05$-0.08$-0.05$-0.06$-0.07$-0.08$-0.08$-0.10$-0.10$-0.10$-0.09$-0.10$-0.11$-0.11$-0.12$-0.12
Low Forecast$-0.01$-0.02$-0.02$-0.05$-0.01$-0.02$-0.02$-0.04$-0.01$-0.03$-0.04$-0.05$-0.03$-0.06$-0.06$-0.09$-0.06$-0.06$-0.07$-0.08$-0.08$-0.10$-0.10$-0.10$-0.09$-0.10$-0.11$-0.11$-0.12$-0.12
Surprise %------------0.27%0.75%1.28%1.05%1.38%0.84%0.68%0.85%0.68%0.74%0.92%1.00%1.03%0.80%0.82%0.91%1.03%1.08%

According to undefined Wall Street analysts, Cerus's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CERS previous annual EPS of $NaN (undefined).

Cerus Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
RPIDRapid Micro Biosystems$1.06$8.00654.72%Hold
ARAYAccuray$1.91$6.00214.14%Buy
CUTRCutera$0.35$1.00185.71%Hold
LUNGPulmonx$6.13$13.00112.07%Buy
SGHTSight Sciences$3.62$7.50107.18%Hold
MXCTMaxCyte$4.27$8.0087.35%Buy
CERSCerus$1.69$3.0077.51%Buy
KIDSOrthoPediatrics$22.46$39.5075.87%Buy
BRKRBruker$57.81$79.0036.65%Buy
CNMDCONMED$71.23$97.0036.18%Buy
OFIXOrthofix Medical$17.93$24.0033.85%
SIBNSI-BONE$13.84$18.5033.67%Buy
NPCENeuroPace$11.52$15.0030.21%Buy
ITGRInteger$136.68$153.5012.31%Buy
CVRXCVRx$13.16$14.258.28%Buy
BVSBioventus$11.15$12.007.62%Buy
ESTAEstablishment Labs$44.67$45.000.74%Buy
SRDXSurmodics$39.96$39.50-1.15%Buy
GKOSGlaukos$146.35$144.14-1.51%Buy

CERS Forecast FAQ


Is Cerus a good buy?

Yes, according to 4 Wall Street analysts, Cerus (CERS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of CERS's total ratings.

What is CERS's price target?

Cerus (CERS) average price target is $3 with a range of $3 to $3, implying a 87.50% from its last price of $1.6. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cerus stock go up soon?

According to Wall Street analysts' prediction for CERS stock, the company can go up by 87.50% (from the last price of $1.6 to the average price target of $3), up by 87.50% based on the highest stock price target, and up by 87.50% based on the lowest stock price target.

Can Cerus stock reach $2?

CERS's average twelve months analyst stock price target of $3 supports the claim that Cerus can reach $2 in the near future.

What are Cerus's analysts' financial forecasts?

Cerus's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $221.24M (high $232.67M, low $209.21M), average EBITDA is $-95.394M (high $-90.205M, low $-100M), average net income is $-13.907M (high $-12.516M, low $-15.301M), average SG&A $143.11M (high $150.51M, low $135.33M), and average EPS is $-0.075 (high $-0.0675, low $-0.0825). CERS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $232.32M (high $244.42M, low $220.29M), average EBITDA is $-100M (high $-94.984M, low $-105M), average net income is $-15.761M (high $-14.701M, low $-16.828M), average SG&A $150.28M (high $158.11M, low $142.5M), and average EPS is $-0.085 (high $-0.0793, low $-0.0908).

Did the CERS's actual financial results beat the analysts' financial forecasts?

Based on Cerus's last annual report (Dec 2023), the company's revenue was $156.4M, which missed the average analysts forecast of $188.36M by -16.97%. Apple's EBITDA was $156.4M, missing the average prediction of $-78.052M by -300.38%. The company's net income was $0, missing the average estimation of $-42.165M by -100.00%. Apple's SG&A was $0, missing the average forecast of $124.88M by -100.00%. Lastly, the company's EPS was $0, missing the average prediction of $-0.222 by -100.00%. In terms of the last quarterly report (Dec 2023), Cerus's revenue was $46.77M, missing the average analysts' forecast of $53.57M by -12.69%. The company's EBITDA was $976K, missing the average prediction of $-23.097M by -104.23%. Cerus's net income was $-1.328M, missing the average estimation of $-5.099M by -73.96%. The company's SG&A was $17.27M, missing the average forecast of $34.65M by -50.16%. Lastly, the company's EPS was $-0.0073, missing the average prediction of $-0.0275 by -73.45%